drugset
drugset / Trial / NCT05720364

Study to Evaluate the Food Effect of TP-05 in Healthy Participants

NCT05720364 ↗

Phase 1 Completed 42 enrolled Tarsus Pharmaceuticals, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

A Phase 1, Open-Label, Randomized, Single-Dose, Parallel-Group Study to Evaluate the Food Effect on the Pharmacokinetics of TP-05 under Fed and Fasted Conditions in Healthy Participants.

Timeline

Start
2023-01-19
Primary completion
2023-05-30
Completion
2023-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject lotilaner Small molecule — Oral

Indications

No indication recorded.